ALX Oncology Holdings, Inc. (ALXO)
2.03
+0.04
(+2.01%)
USD |
NASDAQ |
Aug 25, 14:00
ALX Oncology Holdings Market Cap : 280.58M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 275.05M |
| August 21, 2026 | 281.96M |
| August 20, 2026 | 275.05M |
| August 19, 2026 | 284.73M |
| August 18, 2026 | 287.49M |
| August 17, 2026 | 272.29M |
| August 14, 2026 | 270.90M |
| August 13, 2026 | 268.14M |
| August 12, 2026 | 277.81M |
| August 11, 2026 | 266.76M |
| August 10, 2026 | 284.73M |
| August 07, 2026 | 290.25M |
| August 06, 2026 | 291.64M |
| August 05, 2026 | 265.38M |
| August 04, 2026 | 272.29M |
| August 03, 2026 | 259.66M |
| July 31, 2026 | 261.01M |
| July 30, 2026 | 262.35M |
| July 29, 2026 | 261.68M |
| July 28, 2026 | 267.74M |
| July 27, 2026 | 271.77M |
| July 24, 2026 | 273.12M |
| July 23, 2026 | 271.77M |
| July 22, 2026 | 271.77M |
| July 21, 2026 | 275.81M |
| Date | Value |
|---|---|
| July 20, 2026 | 258.32M |
| July 17, 2026 | 282.54M |
| July 16, 2026 | 278.50M |
| July 15, 2026 | 273.12M |
| July 14, 2026 | 269.08M |
| July 13, 2026 | 265.05M |
| July 10, 2026 | 285.90M |
| July 09, 2026 | 277.15M |
| July 08, 2026 | 313.48M |
| July 07, 2026 | 317.52M |
| July 06, 2026 | 294.64M |
| July 02, 2026 | 278.50M |
| July 01, 2026 | 277.15M |
| June 30, 2026 | 278.50M |
| June 29, 2026 | 295.99M |
| June 26, 2026 | 274.46M |
| June 25, 2026 | 240.83M |
| June 24, 2026 | 240.83M |
| June 23, 2026 | 236.79M |
| June 22, 2026 | 219.30M |
| June 18, 2026 | 205.85M |
| June 17, 2026 | 195.08M |
| June 16, 2026 | 185.67M |
| June 15, 2026 | 212.57M |
| June 12, 2026 | 212.57M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 12.53B |
| Oncolytics Biotech, Inc. | 107.19M |
| Sangamo Therapeutics, Inc. | 66.28M |
| Sarepta Therapeutics, Inc. | 1.995B |
| Anixa Biosciences, Inc. | 130.26M |
Market Cap Related Metrics
| Price to Book Value | 2.060 |
| Price | 2.03 |
| Earnings Yield | -56.06% |